Responses
Clinical/translational cancer immunotherapy
Original research
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
